Stephanie Cahill

Stephanie Cahill has over 25 years of experience in the pharmaceutical research industry. Stephanie began their career in 1994 at AstraZeneca, where they served as a CRA and Clinical Scientist responsible for managing international and local clinical trials. In 2002, Stephanie started their own company, Stephanie Cahill Inc., where they worked as a Clinical Research Consultant and later took on a contract role as a Clinical Research Associate with Boehringer-Ingelheim. Their responsibilities included monitoring and conducting drug and device trials, site selection, and ensuring timely deliverables. Stephanie's expertise also extends to managing phase II-IV trials, particularly in the areas of oncology, pulmonary, emergency bleeding, and COVID-19. In 2023, Stephanie joined Direct Biologics as the VP of Clinical Operations.

Stephanie Cahill is currently pursuing a degree in Nursing at the University of Southampton. Their field of study is Registered Nurse. No information is available regarding the start or end year of their education at this institution.